Unique ID issued by UMIN | UMIN000013598 |
---|---|
Receipt number | R000015887 |
Scientific Title | Phase2 trial of neoadjuvant chemotherapy with S-1 plus radiation in patients with locally advanced rectal cancer |
Date of disclosure of the study information | 2014/04/01 |
Last modified on | 2019/11/06 20:35:23 |
Phase2 trial of neoadjuvant chemotherapy with S-1 plus radiation in patients with locally advanced rectal cancer
Phase2 trial of neoadjuvant
chemotherapy with S-1 plus radiation in patients with locally advanced rectal cancer
Phase2 trial of neoadjuvant chemotherapy with S-1 plus radiation in patients with locally advanced rectal cancer
Phase2 trial of neoadjuvant
chemotherapy with S-1 plus radiation in patients with locally advanced rectal cancer
Japan |
Low rectal cancer
Gastrointestinal surgery |
Malignancy
NO
The purpose of this study was to establish the feasibility and efficacy of preoperative radiation with TS-1 in patients with locally advance rectal cancer
Safety,Efficacy
Phase II
Rate of pathological complete response
Safety
Interventional
Single arm
Non-randomized
Open -no one is blinded
Uncontrolled
1
Treatment
Medicine |
TS-1:80mg/m2-120mg/m2
day1-5,8-12,15-19,22-26,29-33
Radiation:1.8Gy of consecutive 5days,
Total dose 45 Gy
20 | years-old | <= |
80 | years-old | >= |
Male and Female
1.Histologically confirmed low Rectum adenocarcinoma(without Rs)
2.Preoperative CT or MRI findings
the clinical stage is T3-4 and any N
3.Recectable
4.No evidence of peritoneal
metastasis, liver metastasis and
distant metastasis.
5.age:20-80years old
6.Performance status 0-1
7.Without prior anti-tumor therapy
8. Adequate organ function
9.the case can eat
10.Written IC
1.Impossible to receive TS-1 contained chemotherapy
2.Recieving the radiation therapy in a pelvis
3.Infection
4.Serious complications
5.Myocardial infarction within the last 6 months, previous serious medical illness or allergy for drug
6.Multiple malignancies
7. Pleural effusion or ascites requiring
8.Current or previous Brain
metastasis
9.Diarrhea(watery stool)
10.Fresh bleeding of digestive organs
11.Need to treatment with flucytosine, atazanavir sulfate, or warfalin
12.Evidence of psychiatric disability interfering with enrollment to clinical trial
13.Pregnant or lactating women,
women who are capable of pregnancy or intend to get pregnant
14.Man of wanting child
15.Need Systemically administration of corticosteroids
16.Patients judged inappropriate for this study by the physicians
30
1st name | Kimihiko |
Middle name | |
Last name | Funahashi |
Toho University School of Medicine
Division of general and gastroenterological surgery, Department of Surgery (Omori)
143-8541
6-11-1 Omori-Nishi, Ota-ku, Tokyo 143-8541. Japan
03-3762-4151
kingkong@med.toho-u.ac.jp
1st name | Kimihiko |
Middle name | |
Last name | Funahashi |
Division of general and gastroenterological surgery, Department of Surgery (Omori)
Division of general and gastroenterological surgery, Department of Surgery (Omori)
143-8541
6-11-1 Omori-Nishi, Ota-ku, Tokyo 143-8541. Japan
03-3762-4151
kingkong@med.toho-u.ac.jp
Toho University School of Medicine
Toho University
Self funding
Toho University Omori Medical Center
6-11-1 Omorinishi Ota-ku Tokyo, Japan
03-3762-4151
kingkong@med.toho-u.ac.jp
NO
2014 | Year | 04 | Month | 01 | Day |
Unpublished
Completed
2012 | Year | 02 | Month | 01 | Day |
2015 | Year | 06 | Month | 03 | Day |
2013 | Year | 12 | Month | 01 | Day |
2018 | Year | 12 | Month | 01 | Day |
2014 | Year | 04 | Month | 01 | Day |
2019 | Year | 11 | Month | 06 | Day |
Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000015887